JPRN-UMIN000052195尚未招募Unknown
Efficacy and safety of antifibrotic agents for interstitial lung disease associated with rheumatoid arthritis - Efficacy and safety of antifibrotic agents for interstitial lung disease associated with rheumatoid arthritis
Yokohama City University Graduate School of Medicine0 个研究点目标入组 500 人开始时间: 2023年10月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are in conflict with any of the following will not be included in this study: 1. patients complicated with collagen diseases other than RA 2. patients with a hospital history of less than 6 months
研究者
相似试验
招募中
1 期
Clinical study on fibroblast growth factor administration to nasal septal perforatioJPRN-jRCTs031220604Otori Nobuyoshi10
进行中（未招募）
4 期
Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 PneumoniaNovel Coronavirus-induced Lung FibrosisNCT04856111Post Graduate Institute of Medical Education and Research, Chandigarh48
招募中
不适用
Effectiveness of antiresorptive drugs in patients with systemic sclerosis and osteoporosis - a retrospective monocentric studyM80.8M81.8M34Other osteoporosis with pathological fractureOther osteoporosisSystemic sclerosisDRKS00033393Justus-Liebig-Universität, Campus Kerckhoff300
尚未招募
2 期
Effect of antifibrotic therapy on regression of myocardial fibrosis after transcatheter aortic valve implantation (TAVI) in aortic stenosis patients with high fibrotic burdeI50Heart failureDRKS00019893niversitätsmedizin Göttingen150
进行中（未招募）
1 期
Effect of antifibrotic therapy on regression of myocardial fibrosis after transcatheter aortic valve implantation (TAVI) in aortic stenosis patients with high fibrotic burdeCTIS2024-510869-42-00niversitaetsmedizin Goettingen150